2026 Q2 Portfolio Activity
In 2026 Q2, DEERFIELD MANAGEMENT COMPANY, L.P. maintained a portfolio of 95 distinct positions. The most significant new addition was MINERALYS THERAPEUTICS INC, now representing 1.11% of the total fund value. They heavily accumulated shares in BROOKDALE SR LIVING INC, increasing the position by 6137600.0%. Conversely, DEERFIELD MANAGEMENT COMPANY, L.P. completely exited their position in BROOKDALE SR LIVING INC.
Position History
hover any row below to update
Loading…
Total Positions
95
Quarter
2026 Q2
Top Holding
NUVL (22.2%)
Top 10 Concentration
53.2%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 95
DEERFIELD MANAGEMENT COMPANY, L.P. Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NUVL
NUVALENT INC
|
Healthcare | 22.22% | 20.85% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
17,248,450 | $2,130,183,575 | 2021 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
BROOKDALE SR LI...
|
|
Bond/Debt | 6.11% | 5.96% |
#2
Prev: #2
|
4.9 |
—
|
no change | no change |
P
S
|
306,885,000 | $585,704,753 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 4.67% | 2.64% |
#3
4
Prev: #7
|
3.4 |
—
|
95,000 | 4.1% |
P
S
|
2,392,000 | $447,973,760 | 2020 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 3.36% | 3.66% |
#4
Prev: #4
|
2.8 |
—
|
no change | no change |
P
S
|
963,351 | $322,520,281 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VTRS
VIATRIS INC
|
Healthcare | 3.35% | 3.22% |
#5
Prev: #5
|
2.8 |
—
|
no change | no change |
P
S
|
20,206,170 | $320,873,980 | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CNC
CENTENE CORP DE...
|
Healthcare | 3.28% | 2.29% |
#6
5
Prev: #11
|
1.8 |
—
|
-1,016,091 | -17.2% |
P
S
|
4,901,000 | $314,595,190 | 2005 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
REVOLUTION MEDI...
|
|
Bond/Debt | 2.63% | — |
#7
Prev: #—
|
4.6 |
—
|
200,000,000 | — |
NEW
|
200,000,000 | $251,681,000 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
UTHR
UNITED THERAPEU...
|
Healthcare | 2.58% | 3.20% |
#8
2
Prev: #6
|
2.0 |
—
|
no change | no change |
P
S
|
457,000 | $247,616,310 | 2007 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
ARROWHEAD PHARM...
|
|
Bond/Debt | 2.51% | 2.44% |
#9
Prev: #9
|
2.0 |
—
|
no change | no change |
P
S
|
200,000,000 | $240,537,600 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
LEGN
LEGEND BIOTECH ...
|
Healthcare | 2.45% | 1.64% |
#10
8
Prev: #18
|
3.0 |
—
|
450,000 | 5.9% |
P
S
|
8,137,638 | $235,014,985 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 2.02% | 4.11% |
#11
8
Prev: #3
|
0.8 |
—
|
-4,037,799 | -44.6% |
P
S
|
5,006,104 | $193,736,225 | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GMAB
GENMAB A/S
|
Healthcare | 1.97% | 0.78% |
#12
27
Prev: #39
|
3.8 |
—
|
4,403,000 | 178.8% |
P
S
|
6,865,000 | $188,581,550 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BKD
BROOKDALE SR LI...
|
Healthcare | 1.95% | 1.88% |
#13
Prev: #13
|
1.8 |
—
|
no change | no change |
P
S
|
11,637,032 | $187,239,845 | 2007 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 1.75% | 1.77% |
#14
Prev: #14
|
2.7 |
—
|
194,300 | 5.2% |
P
S
|
3,916,400 | $168,052,724 | 2023 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IONS
IONIS PHARMACEU...
|
Healthcare | 1.64% | 1.75% |
#15
Prev: #15
|
1.7 |
—
|
no change | no change |
P
S
|
1,979,669 | $156,967,955 | 2016 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CELC
CELCUITY INC
|
Healthcare | 1.58% | 2.31% |
#16
6
Prev: #10
|
1.1 |
—
|
-262,986 | -15.3% |
P
S
|
1,451,014 | $151,805,085 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BCRX
BIOCRYST PHARMA...
|
Healthcare | 1.57% | 1.69% |
#17
1
Prev: #16
|
1.1 |
—
|
58,403 | 0.4% |
P
S
|
15,096,403 | $150,964,030 | 2005 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NAMS
NEWAMSTERDAM PH...
|
Healthcare | 1.51% | 1.61% |
#18
2
Prev: #20
|
1.6 |
—
|
no change | no change |
P
S
|
4,264,789 | $144,533,699 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ACHC
ACADIA HEALTHCA...
|
Healthcare | 1.39% | 1.25% |
#19
2
Prev: #21
|
1.6 |
—
|
no change | no change |
P
S
|
4,520,000 | $133,475,600 | 2017 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TNGX
TANGO THERAPEUT...
|
Healthcare | 1.37% | 1.02% |
#20
9
Prev: #29
|
1.0 |
—
|
43,798 | 1.1% |
P
S
|
4,190,611 | $130,998,500 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AHCO
ADAPTHEALTH COR...
|
Healthcare | 1.25% | 1.61% |
#21
2
Prev: #19
|
1.5 |
—
|
no change | no change |
P
S
|
11,477,730 | $119,597,947 | 2019 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PHVS
PHARVARIS N V
|
Healthcare | 1.22% | 1.04% |
#22
5
Prev: #27
|
2.5 |
—
|
250,000 | 8.0% |
P
S
|
3,376,042 | $116,743,532 | 2021 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
CELCUITY INC
|
|
Bond/Debt | 1.19% | — |
#23
Prev: #—
|
4.0 |
—
|
100,000,000 | — |
NEW
|
100,000,000 | $113,779,900 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
ARWR
ARROWHEAD PHARM...
|
Healthcare | 1.18% | 1.16% |
#24
2
Prev: #22
|
1.0 |
—
|
-184,242 | -11.7% |
P
S
|
1,389,055 | $113,221,873 | 2013 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 1.14% | 1.01% |
#25
6
Prev: #31
|
2.5 |
—
|
105,500 | 10.3% |
P
S
|
1,125,313 | $109,695,511 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LRMR
LARIMAR THERAPE...
|
Healthcare | 1.13% | 1.89% |
#26
14
Prev: #12
|
1.5 |
—
|
no change | no change |
P
S
|
35,606,974 | $108,601,271 | 2020 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MLYS
MINERALYS THERA...
|
Healthcare | 1.11% | — |
#27
Prev: #—
|
3.9 |
—
|
3,958,000 | — |
NEW
|
3,958,000 | $106,786,840 | 2023 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
ALIGNMENT HEALT...
|
|
Bond/Debt | 1.08% | 1.01% |
#28
2
Prev: #30
|
1.4 |
—
|
no change | no change |
P
S
|
61,000,000 | $103,829,930 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
IDYA
IDEAYA BIOSCIEN...
|
Healthcare | 1.06% | 0.60% |
#29
16
Prev: #45
|
3.4 |
—
|
1,184,495 | 77.4% |
P
S
|
2,714,503 | $101,169,527 | 2019 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
XENE
XENON PHARMACEU...
|
Healthcare | 1.02% | 1.11% |
#30
5
Prev: #25
|
1.4 |
—
|
no change | no change |
P
S
|
1,615,696 | $97,523,411 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
IONIS PHARMACEU...
|
|
Bond/Debt | 0.97% | 1.07% |
#31
5
Prev: #26
|
1.4 |
—
|
no change | no change |
P
S
|
60,000,000 | $93,104,400 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
SVRA
SAVARA INC
|
Healthcare | 0.87% | 0.87% |
#32
3
Prev: #35
|
1.3 |
—
|
no change | no change |
P
S
|
13,569,000 | $83,585,040 | 2018 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LNTH
LANTHEUS HLDGS ...
|
Healthcare | 0.87% | 0.74% |
#33
8
Prev: #41
|
0.8 |
—
|
-75,000 | -9.1% |
P
S
|
752,999 | $83,537,709 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SNDX
SYNDAX PHARMACE...
|
Healthcare | 0.86% | 1.04% |
#34
6
Prev: #28
|
1.3 |
—
|
no change | no change |
P
S
|
3,779,900 | $82,628,614 | 2017 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
ZENAS BIOPHARMA...
|
|
Bond/Debt | 0.84% | 0.79% |
#35
1
Prev: #36
|
0.8 |
—
|
2,200,000 | 3.4% |
P
S
|
67,200,000 | $80,316,096 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
BMRN
BIOMARIN PHARMA...
|
Healthcare | 0.80% | 0.57% |
#36
11
Prev: #47
|
3.3 |
—
|
481,280 | 56.5% |
P
S
|
1,332,836 | $76,264,876 | 2001 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PFE
PFIZER INC
|
Healthcare | 0.76% | 1.01% |
#37
5
Prev: #32
|
1.3 |
—
|
no change | no change |
P
S
|
3,040,000 | $73,203,200 | 2000 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
INDV
INDIVIOR PHARMA...
|
Healthcare | 0.71% | 1.11% |
#38
14
Prev: #24
|
0.3 |
—
|
-1,448,895 | -46.8% |
P
S
|
1,648,895 | $67,654,162 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BIO
BIO RAD LABS IN...
|
Healthcare | 0.69% | 0.74% |
#39
1
Prev: #40
|
1.3 |
—
|
no change | no change |
P
S
|
226,070 | $66,376,413 | 2003 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SPRY
ARS PHARMACEUTI...
|
Healthcare | 0.63% | 0.71% |
#40
2
Prev: #42
|
1.3 |
—
|
no change | no change |
P
S
|
7,503,812 | $60,105,534 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
STOK
STOKE THERAPEUT...
|
Healthcare | 0.62% | 0.70% |
#41
2
Prev: #43
|
1.2 |
—
|
no change | no change |
P
S
|
1,823,500 | $59,664,920 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GPCR
STRUCTURE THERA...
|
Healthcare | 0.61% | 0.44% |
#42
13
Prev: #55
|
2.7 |
—
|
318,007 | 41.4% |
P
S
|
1,086,000 | $58,285,620 | 2023 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NVST
ENVISTA HOLDING...
|
Healthcare | 0.61% | 0.66% |
#43
1
Prev: #44
|
1.2 |
—
|
no change | no change |
P
S
|
2,210,100 | $58,236,135 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
INSP
INSPIRE MED SYS...
|
Healthcare | 0.60% | 1.64% |
#44
27
Prev: #17
|
0.2 |
—
|
-1,406,376 | -52.0% |
P
S
|
1,296,862 | $57,853,014 | 2018 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CDNA
CAREDX INC
|
Healthcare | 0.59% | 0.45% |
#45
9
Prev: #54
|
0.7 |
—
|
-193,382 | -8.8% |
P
S
|
1,997,618 | $56,932,113 | 2014 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BSX
BOSTON SCIENTIF...
|
Healthcare | 0.59% | — |
#46
Prev: #—
|
3.7 |
—
|
1,315,000 | — |
NEW
|
1,315,000 | $56,124,200 | 1999 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BLTE
BELITE BIO INC
|
Healthcare | 0.57% | 0.57% |
#47
1
Prev: #46
|
2.2 |
—
|
53,186 | 17.5% |
P
S
|
357,199 | $55,003,288 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
PARABILIS MEDIC...
|
|
Unknown | 0.54% | — |
#48
Prev: #—
|
3.7 |
—
|
1,880,704 | — |
NEW
|
1,880,704 | $51,474,868 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
CERT
CERTARA INC
|
Healthcare | 0.51% | 0.53% |
#49
Prev: #49
|
0.7 |
—
|
-295,677 | -3.8% |
P
S
|
7,512,928 | $49,209,678 | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IRON
DISC MEDICINE I...
|
Healthcare | 0.50% | 0.50% |
#50
1
Prev: #51
|
1.2 |
—
|
no change | no change |
P
S
|
657,000 | $48,052,980 | 2023 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-50 of 95 holdings